Real-life experience of ledipasvir and sofosbuvir singletablet regimen among chronic hepatitis C patients in Turkey

BACKGROUND/AIMS: Ledipasvir (LDV) and sofosbuvir (SOF) as single-tablet regimen (STR) has been approved for treatment of chronic HCV infection (CHC) for treatment-naïve or experienced cirrhotic or non-cirrhotic patients. Our aim was to analyse the effectiveness and safety of 12–24 weeks treatment of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Turk J Gastroenterol
Autori principali: Yamazhan, Tansu, Turan, İlker, Ersöz, Galip, Günşar, Fulya, Pullukçu, Hüsnü, Danış, Nilay, Ünal, Nalan G., Vardar, Rukiye, Oruç, Nevin, Tekin, Fatih, Taşbakan, Meltem, Sipahi, Oğuz R., Akarca, Ulus S.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Turkish Society of Gastroenterology 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7197924/
https://ncbi.nlm.nih.gov/pubmed/32343236
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2020.19076
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi